The global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028.

Metallo-β-lactamases (MBLs) are a group of enzymes ... This has led to an urgent need for the development of effective inhibitors that can counteract the action of these enzymes.

increase in demand for antimicrobial resistance medication play a major role in the growth of the beta-lactam and beta-lactamase inhibitor market. Furthermore, rise in prevalence of chronic diseases ...

According to the press statement, it is the first completely invented-in-India Beta Lactamase Inhibitor. This pioneering drug recently received the European Medicines Agency’s (EMA ...

with a newer beta-lactamase inhibitor (avibactam), is safe and effective in treating serious infections caused by multidrug-resistant, gram-negative pathogens. Company officials say the results will ...

Recarbrio – which based on established antibiotic combination imipenem/cilastatin with Merck’s new beta-lactamase inhibitor relebactam – has been cleared by the FDA for adults with ...

Qpex’s pipeline revolves around xeruborbactam, an extended-spectrum beta-lactamase inhibitor that is in early-stage clinical testing in both intravenous and oral combinations for infections ...

Together, they’re being studied as a potential treatment option for serious bacterial infections caused by antibiotic-resistant gram-negative bacteria, including Extended Spectrum Beta-lactamase ...

My research is focused on the design, synthesis, and development of new antibiotic agents. I have a long history in the area of beta-lactamase inhibitors. One of these inhibitors, LN-1-255 is now ...

Our current work is directed at solving three main problems: how ß-lactamase inhibitors inactivate -lactamases; how ß-lactamases hydrolyze advanced generation cephalosporins; and how mutations impact ...

The next steps are to extend our beta-lactamase simulation protocols to examine additional ... and to identify how new mechanistic information can be exploited to design new inhibitors of these ...

and beta-lactamases -- Inhibitors of peptidoglycan biosynthesis : penicillins -- Inhibitors of peptidoglycan biosynthesis : cephalosporins -- Inhibitors of peptidoglycan biosynthesis : carbapenems and ...